Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has 823 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 497,273 | 5.02% | $0.00 |
| Capital World Investors | 31 Dec, 2025 | 0 | -132,481 | -0.81% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 731,003 | 33.63% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 364,093 | 8,312.63% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -865,476 | -5.16% | $0.00 |
| Orbis Allan Gray Ltd | 31 Dec, 2025 | 0 | -332,743 | -17.06% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 22,968 | 11.51% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -11,520 | -0.08% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 337,640 | 69.16% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 106,020 | 145.21% | $0.00 |
| Capital Research Global Investors | 31 Dec, 2025 | 0 | -443,132 | -6.14% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -36,602 | -4.51% | $0.00 |
| Osbon Capital Management LLC | 31 Dec, 2025 | 0 | 18 | 0.00% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | -4,367,541 | -48.06% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -22,032 | -3.75% | $0.00 |
| Purpose Unlimited Inc. | 31 Dec, 2025 | 0 | 4 | 0.00% | $0.00 |
| PEAK6 LLC | 31 Dec, 2025 | 0 | 1 | 33.33% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 147,481 | 4.79% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | -621 | -0.14% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 151,480 | 6.06% | $0.00 |